United Kingdom: Food and Drugs Law

A mother shares the heartbreaking story of her 22-year-old daughter's death from ketamine addiction, revealing how recreational drug use spiraled into a debilitating condition called ketamine bladder that caused chronic pain and ultimately led to fatal complications. The case exposes critical gaps in healthcare support for ketamine addiction and raises urgent questions about education, treatment pathways, and the accessibility of this Class B substance.

The phrase "clinically proven" is one of the most powerful claims in a beauty marketer's ‘Arsenal’*. It sounds scientific, authoritative, and reassuring. But in a ruling published in April 2026,...

The MHRA’s proposed rare disease therapies regulatory framework (“the Proposed Framework”) represents an ambitious attempt to redesign medicines regulation around the realities of rare disease development.

Researchers at Wageningen University & Research are revolutionizing agricultural robotics by creating hyper-realistic digital greenhouse environments where robots can train for thousands of hours before entering physical spaces.

The UK's new advertising restrictions on less healthy food and drink products came into force in January, and the Advertising Standards Authority has now issued its first enforcement decisions. These rulings against Iceland, Lidl, German Doner Kebab and On The Beach reveal critical compliance lessons for brands navigating nutrient profiling requirements, supply chain responsibilities, and the boundaries of incidental food appearances in digital advertising.

The UK's Advertising Standards Authority has issued its first four rulings under new regulations restricting advertisements for "less healthy" food and drink products, offering crucial guidance on how these rules will be interpreted and enforced. These decisions reveal which promotional tactics pass muster and which cross the line, with implications for food brands, retailers, and influencers navigating the complex Nutrient Profiling Model requirements. The rulings demonstrate that while some food advertisi

Raj Konanahalli, Consumer Products Partner & Managing Director, discussed how so-called "Big Food" companies are shrinking due to pressures on valuations and are focusing more on their core offerings by disposing the slower, capital-intensive or non-core businesses.

On January 12, 2026, Sanofi announced that the European Commission approved its Teizeild (teplizumab) for delaying progression to stage 3 type 1 diabetes ("T1D") in adults and children eight years...

Artificial Intelligence (AI) is rapidly changing the way people work across the life sciences and healthcare sector.